Drawing for MICROCYCLE

USPTO serial 79335233

MICROCYCLE

Reviewed by CopyMark Law Group

Reg. 6938323Status 700Registered
Filing date
Status date
Registration date
Jan 3, 2023
Examiner
GUROK, GALINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MICROCYCLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce S. Londa

Bruce S. Londa Norris McLaughlin, P.A.7 Times Square21st FloorNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations, namely, biologically compatible chemical substances for scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical researchACTIVE—
005Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and neurological diseases; medical and veterinary preparations for treatment of cancer and neurological diseases; sanitary preparations for medical purposes; dietetic food and dietetic preparations adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology for the treatment of cancer and neurological diseasesACTIVE—
042Drug discovery and pharmaceutical drug development services; scientific services in the nature of scientific research, analysis, and testing in the field of pharmaceuticals and research, development and design relating thereto; medical research; technological services in the nature of pharmaceutical products development and technical consulting in the field of pharmaceutical studies and research and design relating thereto; product design and development of medical technology; product design and development of medical diagnostic apparatus; consultancy services in the field of technological development in the field of medical technology and pharmaceuticals; industrial analysis and industrial research services in the field of medical technology and pharmaceuticals; design and development of computer hardware and software; design and development of software; clinical research, namely, conducting clinical trials for others; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying, namely, scientific research; chemical analysis; chemical research; biotechnology research; consultancy in the field of biotechnologyACTIVE—
044Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease, namely, medical diagnostic testing, monitoring and reporting services; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 17, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 20, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 20, 2023FIMPFINAL DISPOSITION PROCESSED—
Apr 3, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 2, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 29, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 18, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 18, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 8, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 7, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 7, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 7, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2022RFNTREFUSAL PROCESSED BY IB—
May 16, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 16, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 3, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2022DOCKASSIGNED TO EXAMINER—
Mar 15, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance